Skip to main content

Table 2 Knowledge of molecular diagnostics for MDR-TB comparing DTLCs and DACs

From: Gridlock from diagnosis to treatment of multidrug-resistant tuberculosis in Tanzania: low accessibility of molecular diagnostic services and lack of healthcare worker empowerment in 28 districts of 5 high burden TB regions with mixed methods evaluation

Molecular Technology

Characteristic

Sub Category

All

DTLCs

DACs

p - value

GeneXpertMTB/RIF

Description. No. (%)

Understands

37 (70)

22 (81)

15 (57)

0.11

Intermediate understanding

14 (26)

5 (19)

9 (35)

Does not understand

2 (4)

0 (0)

2 (8)

 

Clinical application. No.(%)

Understands

38 (72)

24 (89)

14 (54)

0.015

Intermediate understanding

13 (24)

3 (11)

10 (38)

Does not understand

2 (4)

0 (0)

2 (8)

 

Result interpretation. No. (%)

Understands

22 (42)

16 (59)

6 (23)

0.014

Intermediate understanding

15 (28)

7 (26)

8 (31)

Does not understand

16 (30)

4 (15)

12 (46)

GenotypeMTBDRplus

Description. No. (%)

Understands

10 (19)

8 (30)

2 (8)

0.12

Intermediate understanding

12 (23)

5 (19)

7 (27)

Does not understand

31 (58)

14 (51)

17 (65)

Clinical application. No. (%)

Understands

9 (17)

8 (30)

1 (4)

0.36

Intermediate understanding

14 (26)

7 (26)

7 (27)

Does not understand

30 (57)

12 (44)

18 (69)

Result interpretation. No.(%)

Understands

0 (0)

0 (0)

0 (0)

0.15

Intermediate understanding

5 (9)

1 (4)

4 (15)

Does not understand

48 (91)

26 (96)

22 (85)

  1. DTLC District tuberculosis and leprosy coordinator. DAC District AIDS coordinator